Viracta Therapeutics gets FDA clearance for early stage carcinoma study
July 21 2021 - 8:15AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Apr 2023 to Apr 2024